Contralateral motor deficits after lateral lumbar interbody fusion

Spine

Volumn 38, Issue 22, 2013, Pages 1959-1963

  Taher, Fadi ^a   Hughes, Alexander P ^b   Lebl, Darren R ^b   Sama, Andrew A ^b   Pumberger, Matthias ^a   Aichmair, Alexander ^b   Huang, Russel C ^b   Cammisa, Frank P ^b   Girardi, Federico P ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

complication; contralateral defi cit; extreme lateral interbody fusion; lateral lumbar interbody fusion; LLIF; minimally invasive; motor defi cit.; neurological defi cit; transpsoas approach; XLIF

Indexed keywords

ADULT; AGED; ARTICLE; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HUMAN; LATERAL LUMBAR INTERBODY FUSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOTOR DYSFUNCTION; MUSCLE WEAKNESS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RANGE OF MOTION; SPINE FUSION; SURGICAL APPROACH;

AGED; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; MUSCLE WEAKNESS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SACRUM; SPINAL FUSION;

EID: 84886088037     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3182a463a9     Document Type: Article

References (18)

1. Ozgur BM, Aryan HE, Pimenta L, et al. Extreme lateral interbody fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion. Spine J 2006; 6: 435-43. (Pubitemid 43964530)
2. Isaacs RE, Hyde J, Goodrich JA, et al. A prospective, nonrandom-ized, multicenter evaluation of extreme lateral interbody fusion for the treatment of adult degenerative scoliosis: perioperative outcomes and complications. Spine (Phila Pa 1976) 2010; 35: S322-30.
3. Rodgers WB, Gerber EJ, Patterson J. Intraoperative and early postoperative complications in extreme lateral interbody fusion: an analysis of 600 cases. Spine (Phila Pa 1976) 2011; 36: 26-32.
4. Oliveira L, Marchi L, Coutinho E, et al. A radiographic assessment of the ability of the extreme lateral interbody fusion procedure to indirectly decompress the neural elements. Spine (Phila Pa 1976) 2010; 35: S331-7.
5. Fantini GA, Pappou IP, Girardi FP, et al. Major vascular injury during anterior lumbar spinal surgery: incidence, risk factors, and management. Spine (Phila Pa 1976) 2007; 32: 2751-8. (Pubitemid 350135391)
6. Wood KB, Devine J, Fischer D, et al. Vascular injury in elective anterior lumbosacral surgery. Spine (Phila Pa 1976) 2010; 35: S66-75.
7. Youssef JA, McAfee PC, Patty CA, et al. Minimally invasive surgery: lateral approach interbody fusion: results and review. Spine (Phila Pa 1976) 2010; 35: S302-11.
8. Park DK, Lee MJ, Lin EL, et al. The relationship of intrapsoas nerves during a transpsoas approach to the lumbar spine: anatomic study. J Spinal Disord Tech 2010; 23: 223-8.
9. Guerin P, Obeid I, Gille O, et al. Safe working zones using the minimally invasive lateral retroperitoneal transpsoas approach: a mor-phometric study. Surg Radiol Anat 2011; 33: 665-71.
10. Guerin P, Obeid I, Bourghli A, et al. The lumbosacral plexus: anatomic considerations for minimally invasive retroperitoneal trans-psoas approach. Surg Radiol Anat 2012; 34: 151-7.
11. Pumberger M, Hughes AP, Huang RR, et al. Neurologic defi-cit following lateral lumbar interbody fusion [published online ahead of print December 1, 2011]. Eur Spine J 2012; 21: 1192-9. doi:10.1007/s00586-011-2087-9.
12. Papanastassiou ID, Eleraky M, Vrionis FD. Contralateral femoral nerve compression: an unrecognized complication after extreme lateral interbody fusion (XLIF). J Clin Neurosci 2011; 18: 149-51.
13. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 2011; 11: 471-91.
14. Chen NF, Smith ZA, Stiner E, et al. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphoge-netic protein-2 in transforaminal lumbar interbody fusion. J Neu-rosurg Spine 2010; 12: 40-6.
15. Glassman SD, Howard J, Dimar J, et al. Complications with recombinant human bone morphogenic protein-2 in posterolateral spine fusion: a consecutive series of 1037 cases. Spine (Phila Pa 1976) 2011; 36: 1849-54.
16. Taher F, Lebl DR, Hughes AP, et al. Contralateral psoas seroma after transpsoas lumbar interbody fusion with bone morphogenetic protein-2 implantation [published online ahead of print January 12, 2013]. Spine J 2013; 13: e1-5. doi:10.1016/j.spinee.2012.11.052.
17. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. results of the second national acute spinal cord injury study. N Engl J Med 1990; 322: 1405-11. (Pubitemid 20152525)
18. Walsh KA, Weant KA, Cook AM. Potential benefits of high-dose methylprednisolone in acute spinal cord injuries. Orthopedics 2010; 33: 249-52.